EnilloRing Interactions
There are 458 drugs known to interact with EnilloRing (ethinyl estradiol / etonogestrel), along with 23 disease interactions, and 6 alcohol/food interactions. Of the total drug interactions, 52 are major, 360 are moderate, and 46 are minor.
- View all 458 medications that may interact with EnilloRing
- View EnilloRing alcohol/food interactions (6)
- View EnilloRing disease interactions (23)
Most frequently checked interactions
View interaction reports for EnilloRing (ethinyl estradiol / etonogestrel) and the medicines listed below.
- Botox (onabotulinumtoxinA)
- bupropion
- cetirizine
- cyclobenzaprine
- Emgality (galcanezumab)
- eszopiclone
- FiberCon (polycarbophil)
- lorazepam
- magnesium oxide
- meloxicam
- montelukast
- pantoprazole
- ProAir HFA (albuterol)
- propranolol
- Trintellix (vortioxetine)
- Ubrelvy (ubrogepant)
- Vitamin D3 (cholecalciferol)
EnilloRing alcohol/food interactions
There are 6 alcohol/food interactions with EnilloRing (ethinyl estradiol / etonogestrel).
EnilloRing disease interactions
There are 23 disease interactions with EnilloRing (ethinyl estradiol / etonogestrel) which include:
- smoking
- abnormal genital bleeding
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- breast malignancy
- liver disease
- thromboembolism
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- gallbladder disease
More about EnilloRing (ethinyl estradiol / etonogestrel)
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.